An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes.

Saved in:
Bibliographic Details
Other title:FDA Reauthorization Act of 2017
Format: Government Document Book
Language:English
Published: [Washington, D.C.] : [U.S. Government Publishing Office], 2017.
Subjects:

Norlin Library - Government Information - Reference

Holdings details from Norlin Library - Government Information - Reference
Call Number: AE 2.111:
AE 2.111: (131/PT.1) Restricted Place a Hold

Contents

The following works are all found in the book indicated by the call number above.